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Abstract
Background: It is uncertain whether switching to frequent nocturnal hemodialysis improves cognitive function in
well-dialyzed patients and how this compares to patients who receive a kidney transplant.
Methods: We conducted a multicenter observational study with longitudinal follow-up of the effect on cognitive
performance of switching dialysis treatment modality from conventional thrice-weekly hemodialysis to frequent
nocturnal hemodialysis, a functioning renal transplant or remaining on thrice-weekly conventional hemodialysis.
Neuropsychological tests of memory, attention, psychomotor processing speed, executive function and fluency as
well as measures of solute clearance were performed at baseline and again after switching modality. The change in
cognitive performance measured by neuropsychological tests assessing multiple cognitive domains at baseline, 4
and 12 months after switching dialysis modality were analyzed using a linear mixed model.
Results: Seventy-seven patients were enrolled; 21 of these 77 patients were recruited from the randomized Frequent
Hemodialysis Network (FHN) Nocturnal Trial. Of these, 18 patients started frequent nocturnal hemodialysis, 28 patients
received a kidney transplant and 31 patients remained on conventional thrice-weekly hemodialysis. Forty-eight patients
(62 %) returned for the 12-month follow-up. Despite a significant improvement in solute clearance, 12 months treatment
with frequent nocturnal hemodialysis was not associated with substantial improvement in cognitive performance. By
contrast, renal transplantation, which led to near normalization of solute clearance was associated with clinically relevant
and significant improvements in verbal learning and memory with a trend towards improvements in psychomotor
processing speed. Cognitive performance in patients on conventional hemodialysis remained stable with the exception
of an improvement in psychomotor processing speed and a decline in verbal fluency.
Conclusions: In patients on conventional thrice-weekly hemodialysis, receiving a functioning renal transplant
was associated with improvement in auditory-verbal memory and psychomotor processing speed, which was
not observed after 12 months of frequent nocturnal hemodialysis.
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Background
Cognitive function is impaired in people with chronic
kidney disease (CKD) and correlates with the degree of
kidney dysfunction [1]. In patients with CKD, lower cog-
nitive function is associated with higher rates of mortal-
ity, utilization of health care resources and a lower
quality of life [2–4]. The etiology of cognitive dysfunc-
tion in patients with CKD is multifactorial including the
uremic environment, fluid shifts with dialysis, anemia,
medications, depression, acute illness and structural le-
sions in the brain associated with progressive vascular dis-
ease [4–6]. Previous studies have shown that renal
replacement therapy with dialysis or transplantation is as-
sociated with improvement in cognitive function [7–9].
Patients who receive a renal transplant have been reported
to achieve cognitive function close to normal controls
[10]. However, patients on conventional dialysis, even in
the era of high-flux dialysis, have been reported to have
persistent cognitive deficits [11–14]. Recent studies have
suggested that much of this cognitive dysfunction is asso-
ciated with vascular disease and may not be reversible
with further increases in solute clearance [13, 15, 16].
Compared to conventional thrice-weekly hemodialysis,
frequent hemodialysis 6 days a week increases urea clear-
ance, produces less fluctuation in fluid balance and im-
proves control of blood pressure and serum phosphate,
which might further improve cognitive function. A small,
uncontrolled study found that conversion from conven-
tional thrice-weekly hemodialysis to frequent nocturnal
hemodialysis was associated with improvement in cogni-
tive performance at 6 months [17]. Improvements were
seen in psychomotor efficiency and processing speed as
well as in attention and working memory. However, these
patients were significantly younger and healthier than the
typical hemodialysis patient. The effect of frequent
hemodialysis on cognition was further studied in the Fre-
quent Hemodialysis Network (FHN) Trials, which con-
sisted of two trials: the Daily Trial that randomized
patients with end stage renal disease (ESRD) to treatment
with conventional in-center thrice-weekly hemodialysis
versus in-center hemodialysis 6 days a week and the Noc-
turnal Trial which randomized patients to home or in-
center thrice-weekly hemodialysis versus nocturnal
hemodialysis 6 times per week [18]. Despite increased in-
tensity of dialysis, the FHN Trials found no improvement
in executive function or global cognition in either
Trial [19]. However, exploratory analyses in a subset
of patients who underwent more detailed cognitive
testing revealed improvements in memory and verbal
fluency in the Daily Trial that were not observed in
the Nocturnal Trial [19].
In contrast to frequent hemodialysis, renal transplant-
ation restores renal function to near normal and pro-
vides a better measure of the reversibility of cognitive
deficits seen in patients on conventional hemodialysis.
We therefore extended the cognitive ancillary study of
the FHN Nocturnal Trial to include patients who re-
ceived a functioning kidney transplant and added add-
itional patients outside of the FHN Trial who initiated
nocturnal hemodialysis or remained on conventional
thrice-weekly hemodialysis. The present observational
study explored changes in cognitive function at 4 and
12 months compared to baseline after switching to noctur-
nal hemodialysis 6 days a week, receiving a functioning
renal transplant or remaining on conventional thrice-
weekly hemodialysis.
Methods
Patient population
Patients on conventional thrice-weekly hemodialysis at
one of the participating centers who were eligible to
switch to frequent nocturnal home hemodialysis or were
on the kidney transplant list were invited to participate.
The initial 21 of 77 patients were recruited from the Fre-
quent Hemodialysis Network (FHN) Nocturnal Trial at
one of the five study sites in North America [20]. Details
of the FHN Trials have been published [18]. Some de-
tails on the cognitive effects of frequent nocturnal
hemodialysis for these 21 patients (9 control and 12 noc-
turnal) randomized in the Nocturnal Trial have previ-
ously been published [19]. One patient randomized to
the nocturnal group, returned to conventional thrice-
weekly hemodialysis before the 4-month testing and was
included “as-treated” in the conventional dialysis group
in the present study. After the FHN Trial closed, pa-
tients on conventional hemodialysis at a participating
site who started frequent nocturnal hemodialysis and
met entry criteria for the FNH Trial continued to be re-
cruited to participate in the non-randomized cognitive
study. Subjects for the transplant arm were recruited
from hemodialysis patients at the top of the transplant
waiting list and expected to receive either a deceased
donor or living donor kidney within the next month. Pa-
tients for the conventional arm of the cognitive study
were recruited from hemodialysis patients on the renal
transplant waiting list and not expected to receive a
transplant within the next year. The patients recruited
for the conventional hemodialysis study arm were
matched as closely as possible for baseline characteristics
including age, gender and race of those in the other two
study arms. The trial was approved by the local Institu-
tional Review Board (IRB) at each participating site (see
Additional file 1). All participants signed an IRB-
approved consent to participate in this observational
study. The study adhered to the Declaration of Helsinki.
The FHN Nocturnal trial was registered at Clinical
Trials.gov #NCT 00271999 on 1/6/2006.
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Study factor
Participants who met the inclusion and exclusion criteria
for the FHN Trial [18] were randomized to home noc-
turnal hemodialysis for ≥6 h per night, 6 nights per week
to achieve a weekly target stdKt/V ≥ 4.0/week or
remained on conventional thrice-weekly hemodialysis
≥2.5 h per session with a prescribed eKt/V > 1.1 and
stdKt/V ≥ 2.0 [20]. After the FHN Trial closed, add-
itional patients who started frequent nocturnal
hemodialysis or remained on conventional hemodialysis
were enrolled using the same inclusion and exclusion
criteria into the extended cognitive observational study
and underwent the same intervention and follow-up as
for the FHN Trial. Participants in the transplant group
underwent kidney transplant per the standard of care in
their transplant program.
Study design
Baseline data collection and cognitive testing were per-
formed within the month prior to the planned date of
the starting frequent nocturnal hemodialysis or getting a
renal transplant. A second baseline study was performed
Table 1 Neuropsychological tests performed
Test name Cognitive domain(s) Brief Description
American National Adult
Reading Test (ANART)
Estimated premorbid Intelligence Ability of subject to properly pronounce a list of 50
irregular words.
Modified Mini-Mental
Status Exam (3MS)
Dementia and global cognitive function Series of questions testing orientation, memory, arithmetic
ability, attention, repetition, language and visuospatial
drawing ability.
Beck Depression
Inventory (BDI-II)
Depression Multiple choice 21 item questionnaire assessing severity
of depression
Auditory Verbal Learning
Test (AVLT)
Verbal learning and memory Tests subject’s ability to correctly recall a set of 15 words
presented verbally 5 times to test auditory learning. After a
distractor set of 15 different words the subject is asked to
recall the original 15 words either immediately (immediate
recall) or after a delay of 30 min (delayed recall).
Brief Visuospatial Memory
Test –Revised (BVMT-R)
Visuospatial learning and memory Tests subject’s ability to learn and remember 6 geometric
figures and their corresponding spatial locations from a
printed display. The display is presented three times with
free recall (drawing) after each presentation. After
approximately 25 min, the participant is again asked to
draw the display.
Letter-Number Sequencing Working memory and attention Subject is verbally presented a list of numbers (N) and letters
(L) that they must order (and verbally recite) correctly. Starts
with 3 different sets of 2 N + L combos and increases to 3
sets of 8 N + L combos.
N-Back (Computer task) Working and short-term memory Subject is presented with a sequence of stimuli, and the task
consists of indicating when the current stimulus matches the
one from 2 steps earlier in the sequence. Lures (rather than
foils) are used in some tests where the stimulus presented
matches one from either 1 or 3 steps (but not 2 steps) back.
Digit Symbol Test Psychomotor processing speed, working memory Tests subject’s ability to correctly match and write down a
number corresponding with a particular symbol. Score is
number of items completed correctly in 90 s.
Chooser (Choice Reaction
Time) (Computer task)
Psychomotor processing speed and attention Tests subject’s reaction time moving finger from home
button to one of two alternative signal buttons that has
been lit up.
Buttons (Motor Tracking)
(Computer task)
Ability to utilize advanced information (planning) to
improve psychomotor processing speed and attention
Tests subject’s reaction time in repeatedly releasing their
finger from the home button and correctly moving to one
of two alternative buttons in separate columns that become
lit up. Varying levels of cues are offered to determine
whether subject is able to use additional information to
improve performances.
Trail Making Test
forms A and B
Psychomotor processing speed and executive function
(problem solving, planning, organizational skills, selective
attention, inhibitory control, working memory)
Trails A measures time required to connect numbers scattered
on a page in correct sequential order. Trails B measures time
required to connect a series of numbers (1–12) and letters (A-L)
in correct consecutive sequential order (1-A-2-B, etc.).
Controlled Oral Word
Association Test (COWAT)
Verbal fluency, flexibility and initiation. Language Subject is given a certain letter (such as “F”) and must say as
many words as they can think of that start with that letter in
60 s. This is repeated 2 more times with different letters.
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if there was a delay in switching modality. Follow-up
cognitive testing was scheduled for 4 and 12 months
after starting frequent nocturnal hemodialysis or getting
a renal transplant or 4 and 12 months after the baseline
study in the group that remained on conventional
thrice-weekly hemodialysis. Cognitive testing was done
in the morning before noon on a non-dialysis day for all
patients on conventional hemodialysis. Cognitive testing
for patients on nocturnal hemodialysis was done in the
morning at least 2 h after completing hemodialysis. Cog-
nitive testing for patients who received a transplant
could be on any morning before noon.
Neuropsychological testing
Cognitive testing was conducted in a quiet room, free of
distractions using a standardized set of procedures and
scripted language by an examiner trained and supervised
by a neuropsychologist who was very familiar with each
test and the study protocol. The testing required about
90 min and consisted of both computer tasks as well as
pencil and paper tests. A description of the neuro-
psychological studies performed and cognitive domains
tested is shown in Table 1. Where available, alternate
test forms designed to limit practice effects were used
for each follow-up visit.
Analytical approach
Standard descriptive statistics were used to compare
baseline demographic and clinical characteristics be-
tween the three groups. A longitudinal linear regression
model with an unstructured covariance matrix allowing
for correlation between multiple visits was used to
evaluate the change in each cognitive test over time. Pre-
liminary analyses demonstrated that some cognitive tests
exhibited both a significant within group change over
time and a significant difference between groups on
follow-up so a ‘group by follow-up time’ interaction term
was included in the model. In addition to intervention
group, follow-up time, and the ‘group by follow-up time’
interaction, selected baseline demographic and clinical
variables were included in the adjusted model. Baseline
Table 2 Baseline Demographics
Characteristica Control Nocturnal Transplant p
Total Participants (N) 31 18 28
Gender (female, %) 32 39 43 0.698
Age (years) 49.5 ± 15.4 47.9 ± 14.7 49.93 ±
12.75
0.894
Education 0.099
High School Diploma
or Less (%)
48 50 29
Some College (%) 26 44 32
Bachelor’s Degree
or More (%)
26 6 39
Race 0.303
Caucasian (%) 68 50 71
Other (%) 32 50 29
Household Income 0.442
< $20 k 39 28 32
$20 k - $49 k 22 50 32
>$50 k 29 11 18
Unknown/Refused 10 11 18
Diabetes (%) 35 39 25 0.555
Stroke (%) 3.2 11 3.6 0.433
Congestive Heart
Failure (%)
9.7 16.7 3.6 0.317
Smoking 0.464
Never 55 61 57
Used To 23 28 36
Currently 23 11 7
Beck Depression
Inventory-2
14.4 ± 10.6 10.1 ± 5.1 10.3 ± 6.6 0.123
ANART Raw Score 26.3 ± 12.7 26.7 ± 12.0 22.7 ± 12.1 0.457
Modified Mini-Mental Status 85.2 ± 7.6 88.1 ± 5.7 82.9 ± 15.6 0.293
Weekly Std Kt/V 1.38 ± 0.50 1.32 ± 0.32 1.37 ± 0.26 0.854
Pre Dialysis BUN (mg/dL) 55 ± 15 47 ± 15 61 ± 25 0.064
Pre Dialysis Creatinine
(mg/dL)
9.0 ± 3.7 8.0 ± 3.0 9.4 ± 3.8 0.407
Pre Dialysis
Albumin (g/dL)
4.1 ± 0.5 3.8 ± 0.7 4.1 ± 0.5 0.154
Pre Dialysis Weight (Kg) 81.0 ± 20.2 97.1 ± 29.6 88.9 ± 23.9 0.082
Pre Dialysis Phosphorus
(mg/dL)
5.4 ± 1.6 5.3 ± 1.8 5.1 ± 1.6 0.707
Hemoglobin (g/dL) 11.5 ± 1.3 11.5 ± 1.3 12.0 ± 1.8 0.375
Pre Dialysis Systolic Blood
Pressure (mmHg)
147 ± 27 143 ± 31 142 ± 25 0.791
Pre Dialysis Diastolic Blood
Pressure (mmHg)
80 ± 16 79 ± 19 81 ± 16 0.899
Ultra Filtration Volume (L) 2.3 ± 1.7 2.4 ± 1.5 2.9 ± 1.5 0.355
Urea Reduction Ratio (%) 71 ± 9 70 ± 8 72 ± 6 0.606
Vitamin D use (%) 23 63 32 0.027
Medication
Table 2 Baseline Demographics (Continued)
H1 Receptor
antagonist (%)
10 17 11 0.749
Narcotic (%) 19 28 29 0.672
Muscle Relaxant (%) 6.5 5.6 0 0.405
Anti-Convulsant (%) 29 17 11 0.195
Anti-Depressant (%) 23 28 29 0.855
Anti-Emetic (%) 10 17 11 0.749
Anti-Psychotic (%) 3.2 0 7.1 0.460
Anxiolytic (%) 10 11 25 0.225
aContinuous variables expressed as mean ± SD
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variables that associated with each cognitive test at a
univariate significance of 0.10 or less were subsequently
included in a multiple regression analysis and Bayesian
Information Criteria was used to select the final vari-
ables included in the adjusted model. The baseline vari-
ables selected for the regression model on each cognitive
test are listed in Additional file 2: Table S1. Log trans-
formation was performed for Trails A and Trails B tests
and the Chooser task to approximate normality. All
statistical analyses were conducted using SAS, v9.3. All
p-values are two-sided and were not corrected for mul-
tiple testing. A p-value ≤ 0.05 was considered statistically
significant.
Results
Participant characteristics
Seventy-seven patients were enrolled, 21 patients (9 con-
trol and 12 nocturnal) were recruited from the random-
ized FHN Trial and the remaining 56 patients were
enrolled outside of that Trial. A total of 18 patients
underwent frequent nocturnal hemodialysis, 28 patients
underwent kidney transplantation and 31 patients
remained on conventional thrice-weekly hemodialysis.
The baseline demographic and clinical characteristics
are shown in Table 2. For the combined group the aver-
age age was 49 years old, 38 % were female, 58 % had at
least some college education, and 5 % had suffered a
stroke. The mean (±SD) Beck Depression Inventory
score was 11.9 ± 8.3 indicative of mild depression and
the premorbid group IQ estimated by the ANART score
of 25.1 ± 12.3 was slightly above the population average.
At baseline, the average single pool Kt/V was 1.49 ± 0.41,
the serum albumin was 4.0 ± 0.54 mg/dl and the
hemoglobin was 11.7 ± 1.5 g/dL. Histamine H1 antagon-
ist use was reported in 11.7 %, while 9.1 % reported
using a sedative-hypnotic medication and 24.7 % were
prescribed a narcotic. There was no statistically signifi-
cant difference between the three intervention groups in
any baseline parameter except the use of vitamin D
analogs.
Forty-eight patients (62 %) returned for the 12-month
follow-up, 12 patients (67 %) in the nocturnal
hemodialysis group, 13 patients (46 %) in the transplant
group and 23 patients (74 %) on conventional
hemodialysis. Patient flow and reasons for dropout are
shown in Fig. 1. The characteristics of the three groups at
12 months are shown in Table 3. As expected, the weekly
stdKt/V was significantly higher in the group on frequent
nocturnal hemodialysis (5.56 ± 1.12) compared to those on
conventional hemodialysis (2.27 ± 0.21, p < 0.001). At
12 months, the serum creatinine and phosphorus levels
were significantly lower in patients on frequent nocturnal
dialysis compared to conventional hemodialysis and were
reduced significantly further in patients who received a kid-
ney transplant. Patients who received a kidney transplant
also had significantly higher hemoglobin levels. Otherwise
there were no statistically significant differences (including
sedative medications) between the three groups.
Fig. 1 Patient flow diagram
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Effect of intervention on cognition
As shown in Table 4 and Fig. 2, treatment with frequent
nocturnal hemodialysis for 12 months was associated
with a borderline significant, modest improvement in
the number of words recalled on trial 5 of the Auditory
Verbal Learning Test (AVLT-T5, percent change be-
tween 12 months and baseline = 14.8 %, p = 0.048) and a
significant but modest decline in delayed recall on the
Brief Visuospatial Memory Test (BVMT-DR, percent
change = −18.5 %, p = 0.018). No statistically significant
differences occurred over 12 months in any of the other
cognitive tests when compared to baseline.
By contrast, treatment with kidney transplantation was
associated with a statistically significant improvement in
the Auditory Verbal Learning Test (AVLT-T5, percent
change = 20.9 %, p = 0.003), the AVLT learning score (per-
cent change = 35.9 %, p = 0.009), the AVLT immediate re-
call (AVLT-IR, percent change = 31.9 %, p = 0.002), and the
AVLT delayed recall (AVLT-DR, percent change = 23.3 %,
p = 0.012), as well as a trend towards significance in the
Digit Symbol test (percent change = 12.2 %, p = 0.054). At
12 months, transplant patients also showed a significantly
higher verbal fluency (COWAT) score compared with pa-
tients on nocturnal hemodialysis (p = 0.017).
The dropout rate was higher in the transplant group
than the other two groups. In order to rule out dropout
bias, an exploratory analysis was performed to compare
baseline demographics within the transplant group be-
tween those who returned for at least one follow-up and
those transplant participants who dropped out after
baseline. The ANART score and serum albumin levels
were significantly lower in the group who dropped out
and considered a potentially clinically significant con-
founder. However, adjustment for these two variables in
the model did not impact our results. In addition, an
analysis limited to only those patients who completed 3
study visits led to the same conclusions.
Twelve months treatment with conventional hemodialysis
was associated with a statistically significant improvement in
the Digit Symbol test (percent change = 13.4 %, p < 0.001)
and a statistically significant decline in verbal fluency (Con-
trolled Oral Word Association Test, COWAT; percent
change = −23.8 %, p < 0.001) compared to baseline. Other-
wise performance on cognitive testing in patients on con-
ventional hemodialysis remained stable over 12 months.
Discussion
Despite significant improvement in the clearance of urea,
creatinine and phosphorus, 12 months of treatment with
frequent nocturnal hemodialysis did not lead to improve-
ment in cognitive performance across a broad range of
neuropsychological tests. Marginal improvement in a
measure of auditory-verbal memory was observed while
visuospatial memory declined. By contrast, renal transplant-
ation, which led to near normalization of creatinine clear-
ance, normalization of serum phosphorus and correction of
anemia was associated with significant improvements in
memory and learning with a trend towards improvement in
psychomotor processing speed. When compared to
12 months of frequent nocturnal hemodialysis, renal trans-
plantation was associated with a significant improvement in
verbal learning and memory and in verbal fluency.
These results should be viewed in the context of
whether the neurocognitive deficits seen in currently
Table 3 12-month follow-up
Characteristica Control Nocturnal Transplant p
Total Participants (N) 23 12 13
Gender (female, %) 26 25 46 0.397
Age (years) 47.2 ±
13.6
49.9 ±
14.9
48.8 ±
12.7
0.843
Caucasian (%) 70 42 77 0.167
Diabetes (%) 22 30 15 0.802
Stroke (%) 0 10 0 0.222
Congestive Heart
Failure (%)
4 10 0 0.466
Currently smoking (%) 26 0 15 0.429
Beck Depression Index 11.9 ± 10.2 8.8 ± 5.9 7.7 ± 6.2 0.322
Modified Mini-Mental
Status
89.4 ± 4.9 90.3 ± 4.7 89.8 ± 4.3 0.877
Weekly Std Kt/V 2.27 ± 0.21 5.56 ± 1.15 NA 0.001*
Pre Dialysis BUN (mg/dL) 61 ± 17 43 ± 14 NA 0.008*
Pre Dialysis Creatinine
(mg/dL)
10.1 ± 2.8 7.1 ± 3.1 1.5 ± 0.6 0.001*
Pre Dialysis
Albumin (g/dL)
4.1 ± 0.5 4.0 ± 0.4 4.5 ± 0.4 0.136
Pre Dialysis Phosphorus
(mg/dL)
5.8 ± 1.6 4.3 ± 1.6 2.7 ± 0.4 0.001*
Hemoglobin (g/dL) 11.9 ± 1.5 11.3 ± 2.1 13.8 ± 1.2 0.001*
Pre Dialysis Systolic Blood
Pressure (mmHg)
149 ± 26 135 ± 17 NA 0.123
Pre Dialysis Diastolic Blood
Pressure (mmHg)
84 ± 12 76 ± 12 NA 0.098
Ultra Filtration Volume (L) 2.9 ± 1.4 2.2 ± 1.0 NA 0.179
Urea Reduction Ratio (%) 73 ± 8 78 ± 14 NA 0.158
Vitamin D use (%) 27 17 23 0.905
Medication
H1 Receptors (%) 13 8 8 1.000
Narcotic (%) 39 25 23 0.561
Muscle Relaxant (%) 0 8 0 0.250
Anti-Depressant (%) 39 33 31 0.926
Sedative-hypnotic (%) 17 0 0 0.170
Anxiolytic (%) 13 8 8 1.000
Patient Hospitalized (%) 30 42 15 0.357
aContinuous variables expressed as mean ± SD*P<0.05
Dixon et al. BMC Nephrology  (2016) 17:12 Page 6 of 11
Table 4 Effect of study intervention on cognitive testing after 12 months compared to baseline
Testa Cognitive Domain Study Group Percent Change (12 mon –
Baseline)/(Group Baseline
Average)b
P-
value
Group x Time
Interaction
P-value
AVLT_LA_T1 Memory (auditory) Control 1.8 0.726
Nocturnal 13.8 0.307 0.743
Transplant −1.5 0.965
AVLT_LA_T5 Memory (auditory) & Learning Control 9.5 0.081
Nocturnal 14.8 0.048* 0.332
Transplant 20.9 0.003*
AVLT Learning Score Memory (auditory) & Learning Control 14.9 0.213
Nocturnal 9.9 0.681 0.609
Transplant 35.9 0.009*
AVLT_LA_IR Immediate Recall Memory (auditory) Control 16.2 0.151
Nocturnal 3.2 0.864 0.264
Transplant 31.9 0.002*
AVLT_LA_DR Delayed Recall Memory (auditory) Control −0.6 0.825
Nocturnal −5.4 0.242 0.021*
Transplant 23.3 0.012*
BVMT_T1 Memory (visual-motor) Control −10.0 0.191
Nocturnal −11.7 0.203 0.619
Transplant 5.6 0.565
BVMT_T3 Memory (visual-motor) & Learning Control −4.7 0.341
Nocturnal −9.2 0.221 0.215
Transplant 0.9 0.933
BVMT Learning Score Memory (visual-motor) & Learning Control 8.8 0.76
Nocturnal −2.3 0.82 0.302
Transplant −2.2 0.558
BVMT_DR Delayed Recall Memory
(visual-motor)
Control 6.1 0.439
Nocturnal −18.5 0.043* 0.164
Transplant −3.6 0.500
Letter Number Sequence Working Memory Control 5.2 0.594
Nocturnal −0.9 0.982 0.277
Transplant 10.2 0.082
N-Back Working Memory, Attention
(Executive function)
Control −2.3 0.093
Nocturnal 14.0 0.544 0.854
Transplant 18.0 0.995
Digit Symbol Psychomotor processing speed,
(Executive Function)
Control 13.4 0.000*
Nocturnal 3.7 0.305 0.682
Transplant 12.2 0.054*
Chooser
(Choice Reaction Time)
Psychomotor processing speed Control 2.0 0.070
Nocturnal −0.6 0.752 0.591
Transplant 10.1 0.586
Buttons (Motor Tracking) Psychomotor processing speed Control −0.0 0.369
Nocturnal −1.2 0.946 0.558
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well-dialyzed patients with ESRD are reversible [21, 22].
In older studies, dialysis was shown to improve neuro-
cognitive deficits seen in non-dialyzed patients [7]. How-
ever, recent evidence has raised concern that much of
the residual cognitive dysfunction seen in contemporary
well-dialyzed patients may be due to cerebrovascular
disease and might not be reversible with further in-
creases in solute clearance [21, 22]. Impairment of ex-
ecutive function is the most common neurocognitive
deficit in contemporary dialysis patients [13]. A recent
cross-sectional study found that compared with popula-
tion norms, patients on hemodialysis have impaired ex-
ecutive function but not memory performance [14].
Defects in executive function have been linked with
cerebrovascular disease and vascular dementia [23]. Im-
aging studies have confirmed that hemodialysis patients
have more white matter lesions and cerebral atrophy
than controls without CKD [24].
Using modern techniques of renal replacement therapy
the relationship between dialytic clearance and cognition
has been mixed. Cross-sectional studies of patients on
maintenance hemodialysis have not found an association
between variation in measures of uremia or dialytic clear-
ance and cognition [13, 15]. However, the range of variation
in clearance is relatively small. Cognitive performance has
been reported to fluctuate temporally after hemodialysis
with improvement in attention, concentration, verbal and
visual memory and psychomotor speed 24 h after
hemodialysis [25]. A significant decline in auditory memory
and attention was reported after a weekend (67 h) without
dialysis [8]. Switching from thrice weekly to short frequent
daily dialysis did not improve cognitive performance in one
small controlled study [16]. Alternatively, switching to
frequent nocturnal hemodialysis was reported to improve
psychomotor efficiency, attention and working memory in
another small, uncontrolled study [17].
As previously reported, despite improvement in solute
clearance, patients randomized to frequent daily or noc-
turnal hemodialysis in the FHN Trials did not improve
global cognition compared to patients who remained on
conventional thrice-weekly hemodialysis [19]. However,
exploratory analyses in a subgroup of FHN patients who
underwent a battery of neuropsychological tests similar
to the present study, found that 12-months of frequent
daily hemodialysis was associated with a significant im-
provement in memory and borderline improvement in
verbal fluency compared to thrice-weekly hemodialysis
[19]. By contrast, detailed neuropsychological testing in
21 patients randomized in the FHN Nocturnal Trial
showed no improvement after 12-months of frequent
nocturnal hemodialysis compared to conventional
thrice-weekly hemodialysis. Surprisingly, in the Noc-
turnal Trial psychomotor processing speed at 12 months
was found to be worse in patients randomized to frequent
nocturnal hemodialysis compared to patients remaining
on thrice-weekly hemodialysis.
The present study, included the 21 patients random-
ized in the FHN Nocturnal Trial and added an add-
itional cohort of 56 patients, seven of which underwent
frequent nocturnal hemodialysis. The results generally
confirm and extend the observations from the FHN Trial,
revealing that cognitive function, tested over multiple do-
mains, did not improve one year after switching to fre-
quent nocturnal hemodialysis compared to remaining on
conventional thrice-weekly hemodialysis. However, in
contrast to the FHN Trial the present study did not find
Table 4 Effect of study intervention on cognitive testing after 12 months compared to baseline (Continued)
Transplant −7.4 0.275
Trails A Psychomotor Processing
Speed & attention
Control 4.8 0.649
Nocturnal −0.2 0.907 0.660
Transplant −5.1 0.934
Trails B Executive Function Control −4.5 0.867
Nocturnal −20.9 0.187 0.156
Transplant −3.0 0.311
Verbal Fluency (COWAT) Language & Executive Function Control −23.8 0.001*
Nocturnal −14.6 0.080 0.017*
Transplant 3.7 0.929
aSee Table 1 for details on cognitive tests. * P<0.05. AVLT_LA_T1, Auditory Verbal Learning Test, word list A, first administration; AVLT_LA_T5, Auditory Verbal
Learning Test, word list A, fifth administration; AVLT Learning Score, represents the difference in the maximum number of words recalled on the 4th or 5th
administration minus the baseline recall; AVLT_LA_IR, Auditory Verbal Learning Test, word list A, immediate recall; represents immediate recall from word list A
after completion of the distractor list of 15 different words; AVLT_LA_DR, Auditory Verbal Learning Test, word list A, delayed recall; represents delayed recall from
word list A, 30 min after completion of the distractor list of 15 different words; BVMT_T1, Brief Visuospatial Memory Test, first administration; BVMT_T3, Brief
Visuospatial Memory Test, third administration; BVMT Learning Score, measures the mean difference in the maximum and baseline performance on the BVMT at
that study visit; BVMT_DR, Brief Visuospatial Memory Test, delayed recall, measures recall of the original figures following a 25-min delay
bPercent change was computed as the difference between the twelve month visit and baseline visit divided by the average baseline score for the
intervention group
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that psychomotor processing speed was worse with fre-
quent nocturnal hemodialysis compared to conventional
thrice-weekly hemodialysis. This difference may be ex-
plained by the larger sample size and the fact that one pa-
tient randomized to frequent nocturnal hemodialysis had
returned to conventional thrice weekly dialysis before the
4 month cognitive testing was performed and was ana-
lyzed “as treated” in the present study. These results also
do not confirm a previous report that six months of fre-
quent nocturnal hemodialysis significantly improved psy-
chomotor efficiency, processing speed, attention and
working memory [17]. Compared to the present study, the
sample size in that study was smaller and their population
was significantly younger with fewer comorbidities and
did not include a control group. This might suggest that
cognitive function in younger, healthier patients may re-
spond better to frequent nocturnal hemodialysis but this
would need to be examined further.
In contrast to dialysis, renal transplantation provides
nearly complete correction of uremia as well as restor-
ation of renal metabolic and endocrine functions. Con-
sistent with the results of the present study, previous
studies have reported that cognitive function in adult pa-
tients on dialysis can be improved by renal transplant-
ation [9, 10, 26–28]. Improvements in verbal memory
and psychomotor processing speed have been consist-
ently observed while improvements in executive func-
tion and attention have been variable [9, 10, 26–28]. In
contrast to the cognitive deficits seen in well-dialyzed
adult patients on dialysis [11–14], cognitive function in
renal transplant recipients has been reported to be indis-
tinguishable from matched normal controls [26, 29].
Taken together, these results demonstrate that some of
the cognitive deficits seen in well dialyzed adult patients,
particularly in memory and psychomotor processing
speed can be reversed by renal transplantation. Improve-
ment in cognition with renal transplantation could be
mediated by several factors including reversal of endo-
crine or metabolic dysfunction, correction of anemia
[30, 31], better control of blood pressure, fluid and elec-
trolytes. However, improvement in excretory function
leading to better clearance of uremic toxins likely plays
an important role in mediating the improvement in
Fig. 2 Change in selected cognitive tests at 4 and 12 months after
switching to frequent nocturnal hemodialysis (circles, ○) receiving a
renal transplant (triangles, Δ) or remaining on conventional thrice-
weekly hemodialysis (squares, □). Data shows analysis after adjust-
ment for difference in baseline characteristics as described in
Additional file 2: Table S1. Refer to Table 1 and legend to Table 4
for a description of the tests and abbreviations. Dashed lines
represent statistically significant (p < 0.05) within group changes in test
performance between 12 months and baseline. Vertical lines with the
associated p-value represent statistically significant (p < 0.05) pairwise
differences between study groups at the specified study visit
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cognition following renal transplantation. The observed
improvement of approximately 2 words in verbal learn-
ing and memory scores for transplant patients represents
a clinically meaningful 19–35 % improvement over base-
line and moves these scores into the normal range for
age and education.
Taken together these results suggest that there are defi-
cits in memory and verbal fluency in patients on thrice-
weekly hemodialysis that can be improved by switching to
frequent daily hemodialysis or receiving a renal transplant
but not frequent nocturnal hemodialysis. Processing speed
may also be improved by renal transplantation. In contrast,
attention and executive function did not improve with fre-
quent dialysis and has been inconsistently reported to im-
prove following renal transplantation. While further work
is needed, these results are consistent with the observation
that impairment in executive function is associated with
vascular disease and fixed structural lesions in the brain
that are not readily reversible with increased solute clear-
ance. The apparent lack of benefit of frequent nocturnal
hemodialysis compared to frequent daily dialysis despite
greater improvement in dialytic clearance was unexpected.
This may be due to the small sample size of the studies.
However, it is also possible that nocturnal dialysis
may affect sleep patterns or otherwise adversely affect
mental alertness that could counterbalance the posi-
tive effect of increased solute clearance on cognitive
performance.
To our knowledge the present study is the largest study
of the effect of frequent nocturnal hemodialysis on cogni-
tion. Notable additional strengths include the broad bat-
tery of neuropsychological tests employed, use of alternate
test forms to minimize practice effects and the inclusion
of both control groups for conventional thrice-weekly
hemodialysis and renal transplantation. Nevertheless, the
study was limited by patient dropout that truncated mean-
ingful follow-up to an average of 12 months. In addition,
the study population was relatively high functioning and
the results may not generalize to general hemodialysis
populations.
Conclusions
For patients on conventional thrice-weekly hemodialysis
receiving a functioning renal transplant was associated with
improvement in auditory-verbal memory and psychomotor
processing speed that was not observed after 12 months of
frequent nocturnal hemodialysis. The lack of improvement
in cognition with frequent nocturnal hemodialysis despite
significant improvement in solute clearance was unex-
pected and requires further investigation.
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